These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 32860162)

  • 41. Identification of novel GCK and HNF1A/TCF1 mutations and polymorphisms in German families with maturity-onset diabetes of the young (MODY).
    Toaima D; Näke A; Wendenburg J; Praedicow K; Rohayem J; Engel K; Galler A; Gahr M; Lee-Kirsch MA
    Hum Mutat; 2005 May; 25(5):503-4. PubMed ID: 15841481
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mutations in HNF1A result in marked alterations of plasma glycan profile.
    Thanabalasingham G; Huffman JE; Kattla JJ; Novokmet M; Rudan I; Gloyn AL; Hayward C; Adamczyk B; Reynolds RM; Muzinic A; Hassanali N; Pucic M; Bennett AJ; Essafi A; Polasek O; Mughal SA; Redzic I; Primorac D; Zgaga L; Kolcic I; Hansen T; Gasperikova D; Tjora E; Strachan MW; Nielsen T; Stanik J; Klimes I; Pedersen OB; Njølstad PR; Wild SH; Gyllensten U; Gornik O; Wilson JF; Hastie ND; Campbell H; McCarthy MI; Rudd PM; Owen KR; Lauc G; Wright AF
    Diabetes; 2013 Apr; 62(4):1329-37. PubMed ID: 23274891
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes.
    Besser RE; Shepherd MH; McDonald TJ; Shields BM; Knight BA; Ellard S; Hattersley AT
    Diabetes Care; 2011 Feb; 34(2):286-91. PubMed ID: 21270186
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The HNF1A mutant Ala180Val: Clinical challenges in determining causality of a rare HNF1A variant in familial diabetes.
    Sagen JV; Bjørkhaug L; Haukanes BI; Grevle L; Molnes J; Nedrebø BG; Søvik O; Njølstad PR; Johansson S; Molven A
    Diabetes Res Clin Pract; 2017 Nov; 133():142-149. PubMed ID: 28934671
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic Confirmation Rate in Clinically Suspected Maturity-Onset Diabetes of the Young.
    Brahm AJ; Wang G; Wang J; McIntyre AD; Cao H; Ban MR; Hegele RA
    Can J Diabetes; 2016 Dec; 40(6):555-560. PubMed ID: 27634015
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A decision algorithm to identify patients with high probability of monogenic diabetes due to HNF1A mutations.
    Szopa M; Klupa T; Kapusta M; Matejko B; Ucieklak D; Glodzik W; Zapala B; Sani CM; Hohendorff J; Malecki MT; Skupien J
    Endocrine; 2019 Apr; 64(1):75-81. PubMed ID: 30778899
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Maturity onset diabetes of the young due to
    Pavić T; Juszczak A; Pape Medvidović E; Burrows C; Šekerija M; Bennett AJ; Ćuća Knežević J; Gloyn AL; Lauc G; McCarthy MI; Gornik O; Owen KR
    Biochem Med (Zagreb); 2018 Jun; 28(2):020703. PubMed ID: 29666556
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MODY in Ukraine: genes, clinical phenotypes and treatment.
    Globa E; Zelinska N; Elblova L; Dusatkova P; Cinek O; Lebl J; Colclough K; Ellard S; Pruhova S
    J Pediatr Endocrinol Metab; 2017 Oct; 30(10):1095-1103. PubMed ID: 28862987
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Half of clinically defined maturity-onset diabetes of the young patients in Denmark do not have mutations in HNF4A, GCK, and TCF1.
    Johansen A; Ek J; Mortensen HB; Pedersen O; Hansen T
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4607-14. PubMed ID: 15928245
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinical characteristics and genetic analysis of children and adolescents with monogenic diabetes].
    Fang J; Zhang P; Feng Y; Ding S; Yan L; Li H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2024 Jul; 41(7):783-789. PubMed ID: 38946358
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Heterozygous lys169Glu mutation of glucokinase gene in a Chinese family having glucokinase-maturity-onset diabetes of the young (GCK-MODY).
    Zhou W; Chen M; Zhou H; Zhang Z
    J Postgrad Med; 2019; 65(4):241-243. PubMed ID: 31571622
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes.
    Thanabalasingham G; Shah N; Vaxillaire M; Hansen T; Tuomi T; Gašperíková D; Szopa M; Tjora E; James TJ; Kokko P; Loiseleur F; Andersson E; Gaget S; Isomaa B; Nowak N; Raeder H; Stanik J; Njolstad PR; Malecki MT; Klimes I; Groop L; Pedersen O; Froguel P; McCarthy MI; Gloyn AL; Owen KR
    Diabetologia; 2011 Nov; 54(11):2801-10. PubMed ID: 21814873
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Maturity-onset diabetes of the young (MODY) in Brazil: Establishment of a national registry and appraisal of available genetic and clinical data.
    Giuffrida FMA; Moises RS; Weinert LS; Calliari LE; Manna TD; Dotto RP; Franco LF; Caetano LA; Teles MG; Lima RA; Alves C; Dib SA; Silveiro SP; Dias-da-Silva MR; Reis AF;
    Diabetes Res Clin Pract; 2017 Jan; 123():134-142. PubMed ID: 28012402
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations.
    Owen KR; Thanabalasingham G; James TJ; Karpe F; Farmer AJ; McCarthy MI; Gloyn AL
    Diabetes Care; 2010 Sep; 33(9):1919-24. PubMed ID: 20724646
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Three unreported glucokinase (GCK) missense mutations detected in the screening of thirty-two Brazilian kindreds for GCK and HNF1A-MODY.
    Weinert LS; Silveiro SP; Giuffrida FM; Cunha VT; Bulcão C; Calliari LE; Della Manna T; Kunii IS; Dotto RP; Dias-da-Silva MR; Reis AF
    Diabetes Res Clin Pract; 2014 Nov; 106(2):e44-8. PubMed ID: 25174781
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic and Clinical Characterization of Patients with Maturity-Onset of Diabetes of the Young (MODY): Identification of Novel Variations.
    Ateş EA; Üstay Ö; Polat H; Apaydın T; Elbasan O; Yıldırım Ö; Güney Aİ
    Balkan Med J; 2021 Sep; 38(5):272-277. PubMed ID: 34462253
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Common variants in maturity-onset diabetes of the young genes contribute to risk of type 2 diabetes in Finns.
    Bonnycastle LL; Willer CJ; Conneely KN; Jackson AU; Burrill CP; Watanabe RM; Chines PS; Narisu N; Scott LJ; Enloe ST; Swift AJ; Duren WL; Stringham HM; Erdos MR; Riebow NL; Buchanan TA; Valle TT; Tuomilehto J; Bergman RN; Mohlke KL; Boehnke M; Collins FS
    Diabetes; 2006 Sep; 55(9):2534-40. PubMed ID: 16936201
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of HNF1A-MODY and HNF4A-MODY in Irish families: phenotypic characteristics and therapeutic implications.
    Kyithar MP; Bacon S; Pannu KK; Rizvi SR; Colclough K; Ellard S; Byrne MM
    Diabetes Metab; 2011 Dec; 37(6):512-9. PubMed ID: 21683639
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia.
    Colclough K; Bellanne-Chantelot C; Saint-Martin C; Flanagan SE; Ellard S
    Hum Mutat; 2013 May; 34(5):669-85. PubMed ID: 23348805
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of hepatocyte nuclear factor-1A and -4A on pancreatic stone protein/regenerating protein and C-reactive protein gene expression: implications for maturity-onset diabetes of the young.
    Kyithar MP; Bonner C; Bacon S; Kilbride SM; Schmid J; Graf R; Prehn JH; Byrne MM
    J Transl Med; 2013 Jun; 11():156. PubMed ID: 23803251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.